1.14
price up icon0.00%   0.00
after-market アフターアワーズ: 1.15 0.01 +0.88%
loading
前日終値:
$1.14
開ける:
$1.17
24時間の取引高:
419.30K
Relative Volume:
0.13
時価総額:
$150.49M
収益:
$3.25M
当期純損益:
$-116.80M
株価収益率:
-0.3738
EPS:
-3.05
ネットキャッシュフロー:
$-98.17M
1週間 パフォーマンス:
-3.39%
1か月 パフォーマンス:
-27.85%
6か月 パフォーマンス:
-63.69%
1年 パフォーマンス:
-95.39%
1日の値動き範囲:
Value
$1.1225
$1.17
1週間の範囲:
Value
$1.11
$1.23
52週間の値動き範囲:
Value
$0.7893
$27.35

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
名前
Rapt Therapeutics Inc
Name
セクター
Healthcare (1173)
Name
電話
(650) 489-9000
Name
住所
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
職員
70
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
RAPT's Discussions on Twitter

RAPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RAPT
Rapt Therapeutics Inc
1.14 150.49M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-26 アップグレード H.C. Wainwright Neutral → Buy
2024-11-13 ダウングレード Stifel Buy → Hold
2024-11-11 ダウングレード JP Morgan Neutral → Underweight
2024-11-11 ダウングレード Piper Sandler Overweight → Neutral
2024-05-14 ダウングレード Wolfe Research Outperform → Peer Perform
2024-05-10 ダウングレード Barclays Overweight → Equal Weight
2024-05-10 ダウングレード Guggenheim Buy → Neutral
2024-02-22 ダウングレード UBS Buy → Neutral
2024-02-21 ダウングレード H.C. Wainwright Buy → Neutral
2024-02-21 ダウングレード JP Morgan Overweight → Neutral
2024-02-21 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-20 ダウングレード Cantor Fitzgerald Overweight → Neutral
2024-02-16 開始されました Evercore ISI Outperform
2024-02-15 開始されました Wolfe Research Outperform
2023-09-14 開始されました Berenberg Buy
2023-08-09 開始されました Stifel Buy
2023-06-15 開始されました Barclays Overweight
2023-01-04 開始されました Guggenheim Buy
2022-12-01 開始されました Goldman Buy
2022-09-21 開始されました CapitalOne Overweight
2022-05-24 再開されました Cantor Fitzgerald Overweight
2021-12-09 開始されました JP Morgan Overweight
2021-08-12 開始されました SVB Leerink Outperform
2021-06-21 開始されました Piper Sandler Overweight
2020-06-01 開始されました H.C. Wainwright Buy
2020-05-19 開始されました Cantor Fitzgerald Overweight
2020-04-13 開始されました ROTH Capital Buy
2019-11-25 開始されました BMO Capital Markets Outperform
2019-11-25 開始されました UBS Buy
2019-11-25 開始されました Wells Fargo Outperform
すべてを表示

Rapt Therapeutics Inc (RAPT) 最新ニュース

pulisher
Jan 29, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

Form 424B3 RAPT Therapeutics, Inc. - StreetInsider.com

Jan 28, 2025
pulisher
Jan 28, 2025

SEC Form 424B3 filed by RAPT Therapeutics Inc. - Quantisnow

Jan 28, 2025
pulisher
Jan 26, 2025

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull - MSN

Jan 26, 2025
pulisher
Jan 25, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Stake Boosted by Barclays PLC - Defense World

Jan 25, 2025
pulisher
Jan 14, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

RAPT Therapeutics Plans Phase 2b Trials for RPT904 - TipRanks

Jan 13, 2025
pulisher
Jan 10, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Purchased by Barclays PLC - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 09, 2025
pulisher
Jan 08, 2025

RAPT Therapeutics appoints new board chair By Investing.com - Investing.com Nigeria

Jan 08, 2025
pulisher
Jan 06, 2025

RAPT Therapeutics appoints new board chair - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

RAPT Therapeutics, Inc. Announces Board Changes - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors - Yahoo Finance

Jan 06, 2025
pulisher
Jan 04, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $9.56 Average Target Price from Brokerages - MarketBeat

Jan 04, 2025
pulisher
Jan 04, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of “Hold” from Analysts - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - News & Insights

Jan 03, 2025
pulisher
Dec 30, 2024

Short Interest in RAPT Therapeutics, Inc. (NASDAQ:RAPT) Grows By 25.5% - MarketBeat

Dec 30, 2024
pulisher
Dec 28, 2024

Notable analyst calls this week: FREYR Battery, Apple and ServiceNow among top picks - Seeking Alpha

Dec 28, 2024
pulisher
Dec 27, 2024

Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright - Yahoo Finance

Dec 27, 2024
pulisher
Dec 27, 2024

RAPT Therapeutics (NASDAQ:RAPT) Upgraded by HC Wainwright to Buy Rating - Defense World

Dec 27, 2024
pulisher
Dec 26, 2024

RAPT rockets 180% on licensing deal, $150M private placement (update) - MSN

Dec 26, 2024
pulisher
Dec 26, 2024

RAPT Therapeutics Shares Surge After HC Wainwright Upgrade - Marketscreener.com

Dec 26, 2024
pulisher
Dec 26, 2024

HC Wainwright & Co. Upgrades RAPT Therapeutics (RAPT) - MSN

Dec 26, 2024
pulisher
Dec 26, 2024

RAPT upgraded at H.C. Wainwright on China licensing deal - MSN

Dec 26, 2024
pulisher
Dec 26, 2024

RAPT stock upgraded at H.C. Wainwright (RAPT:NASDAQ) - Seeking Alpha

Dec 26, 2024
pulisher
Dec 26, 2024

RAPT Therapeutics (NASDAQ:RAPT) Upgraded by HC Wainwright to "Buy" Rating - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday - Benzinga

Dec 26, 2024
pulisher
Dec 25, 2024

RAPT Therapeutics Announces License Agreement and Private Placement - Defense World

Dec 25, 2024
pulisher
Dec 24, 2024

RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics soars as it looks to raise $150M in private placement - MSN

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement - Mugglehead

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics, Inc. announced that it expects to receive $149.976555 million in funding from a group of investors - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics stock rises following licensing deal with Jemincare By Investing.com - Investing.com Nigeria

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics stock rises following licensing deal with Jemincare - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Peninsula drugmaker lands $150 million, food allergy drug to fill pipeline holeSan Francisco Business Times - The Business Journals

Dec 23, 2024
pulisher
Dec 23, 2024

Why RAPT Therapeutics Stock Gained Over 100% On Monday? - Yahoo Finance

Dec 23, 2024
pulisher
Dec 23, 2024

US Stocks Mixed, Dow Tumbles 150 Points - Benzinga

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics secures rights to new allergy antibody - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics Partners with Jemincare and Secures Funding - TipRanks

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics prices 100M shares at 85c in private placement - TipRanks

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics Announces $150 Million Private Placement - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement - The Bakersfield Californian

Dec 23, 2024
pulisher
Dec 23, 2024

RAPT Therapeutics Secures $672.5M Deal for Breakthrough Anti-IgE Antibody with Extended Half-Life - StockTitan

Dec 23, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Cuts Stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Dec 20, 2024
pulisher
Dec 15, 2024

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings? - MSN

Dec 15, 2024
pulisher
Dec 13, 2024

RAPT Therapeutics stock plunges to 52-week low of $0.92 - Investing.com India

Dec 13, 2024
pulisher
Dec 13, 2024

RAPT Therapeutics' SWOT analysis: stock faces challenges amid pipeline setbacks - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

RAPT Therapeutics stock plunges to 52-week low of $0.92 By Investing.com - Investing.com Nigeria

Dec 13, 2024

Rapt Therapeutics Inc (RAPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):